ESOI/EORTC Autumn Workshop 2017
Imaging in assessing response to cancer therapy - a hands-on course
November 14-16, 2017
Barcelona, Spain

This workshop is fully booked! .

M. D'Anastasi, Msida/MT
L. Donoso Bach, Barcelona/ES

Y. Liu, Brussels/BE

The ESOI/EORTC workshop is an interactive hands-on course aimed at practising radiologists and radiology residents, focusing on the critieria-based assessment of tumor response to treatment. The course consists of a number of lectures explaining the principles of imaging-based tumour response assessment and several hands-on interactive training workshops using specialised software with common and rare cancer cases encountered in the clinical routine or within clinical trials.

Learning objectives

EORTC test
Participants will have the unique opportunity to sit for a qualification test on using RECIST 1.1 at the end of the workshop. Successful participants will receive a RECIST qualification certificate from the ESOI and EORTC. Qualified radiologists will then have the option to become independent imaging reviewers for future EORTC studies.

CME Accreditation
The workshop has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 14 European CME credits (ECMEC®s).

Alimara Hotel Barcelona
Medes + Capri Meeting Room
Berruguete, 126  
08035 Barcelona

*Pease note that this programme might be subject to changes.

Tuesday, November 14, 2017
Medes meeting room

08:30-08:55 Registration
Welcome and introduction
  Session 1
09:00-09:30 Lecture: RECIST criteria, the basics
M. D'Anastasi, Msida/MT
Workstation familiarisation
Coffee break
11:00-12:00 WS: How to choose and measure target lesions
M. D'Anastasi, Msida/MT
WS: How to deal with non-target lesions
S. Gourtsoyianni, Athens/GR
Lunch break
  Session 2
14:00-14:30 Lecture: RECIST criteria, critical issues
D. Regge, Turin/IT
WS: RECIST training challenging cases - I
G. Zamboni, Verona/IT
Coffee break
16:00-17:00 WS: RECIST training challenging cases - II
L. Fournier, Paris/FR
17:00-17:25 Lecture: Therapy monitoring and criteria-based reporting in hybrid imaging
C. Cyran, Munich/DE
17:25-17:30 Q&A
17:30-17:35 Closing remarks

Wednesday, November 15, 2017
Medes meeting room

  Session 3
09:00-09:30 Lecture: New cancer therapies, what imaging doctors must know
J. Garcia-Corbacho, Barcelona/ES
09:30-10:00 Lecture: Beyond RECIST, modified criteria
M. Ronot, Clichy/FR


Coffee break
10:30-11:00 Lecture: Assessment of bone lesions: pearls and pitfalls
F. Lecouvet, Brussels/BE
11:00-12:00 WS: Assessing response in GIST
D. Regge, Turin/IT
WS: Assessing response in HCC
C. Ayuso, Barcelona/ES
Lunch break
  Session 4
14:00-15:30 WS: Assessing response to immune therapy
O. Sedlaczek, Heidelberg/DE
Coffee break
16:00-17:30 WS: Assessing response in lymphoma
M. Mayerhoefer, Vienna/AT
17:30-18:00 Lecture: The role of imaging in oncology
E. Neri, Pisa/IT
18:00-18:05 Closing remarks

Thursday, November 16, 2017
Medes meeting room

  Session 5
09:00-09:30 Lecture: Imaging in therapy toxicity
O. Sedlaczek, Heidelberg/DE
09:30-09:50 Lecture: What radiologists should know about clinical trials and trials methodology
S. Collette, Brussels/BE
09:50-10:15 New insights lecture: Imaging Biomarkers - from development to use in daily practice
J. O'Conner, Manchester/UK
Open coffee break
  EORTC Test
10:45-12.55 RECIST qualification
L. Fournier, Paris/FR
12.55-13.00 Closing remarks